Hologic outlines growth strategy in women’s health, shares on NASDAQ in medtech peer focus

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-24, 09:11.

Hologic (US4364401012) positions itself as a focused medical technology company in women’s health diagnostics and related products, with its shares listed on NASDAQ in the United States.Company overview from Hologic The group’s long-term strategy centers on imaging, surgical and diagnostic solutions that aim to improve women’s health outcomes.

Long-term revenue development

Over the last 19 years, Hologic has grown its revenue by an average of around 12 percent per year, according to data aggregators that track the company’s financials.Eulerpool revenue history for Hologic In 2026, sales are reported at roughly 4.1 billion US dollars, a modest increase versus the previous year’s level.

This revenue trajectory places Hologic among mid-sized medtech players that focus on diagnostics rather than large-scale pharmaceutical pipelines, in contrast to diversified peers such as Abbott Laboratories and Roche. The company’s growth pattern reflects continued demand for breast health screening, gynecologic surgery tools and molecular diagnostics.

Business focus in diagnostics

Hologic’s portfolio is built around imaging, diagnostic and surgical platforms for women’s health, including mammography systems, biopsy devices and minimally invasive gynecologic instruments.Hologic breast health solutions overview The group also provides molecular diagnostic assays and instrumentation used in laboratories for infectious disease testing and cervical cancer screening.

The company emphasizes technology that aims to increase accuracy and efficiency in clinical workflows, particularly in breast cancer detection and gynecologic procedures. Its systems are typically sold to hospitals, imaging centers and laboratories, generating a mix of equipment, consumables and service revenue streams over time.

The products behind the stock

One of Hologic’s flagship product families is its 3D mammography platform, marketed under the Selenia Dimensions brand for digital breast tomosynthesis and related imaging workflows.Hologic Selenia Dimensions product page These systems are used in breast screening programs to detect cancer at earlier stages through high-resolution imaging and advanced reconstruction software.

Where the shares trade today

The Hologic shares (US4364401012) trade on NASDAQ in the United States, with the price quoted in US dollars at the latest available close. The listing places the company among a broad group of healthcare and medical technology stocks monitored by international investors.

Disclaimer: This text is for informational purposes only and does not constitute investment advice, tax advice or a recommendation to buy or sell financial instruments. All data have been compiled with care but without guarantee.